401 filings
Page 5 of 21
8-K
edebgrlb8c
2 Jun 08
Erbitux® (Cetuximab) Data Demonstrate Improved Overall Survival In First-line Treatment of Advanced Non-small Cell Lung Cancer
12:00am
8-K
pyx8ufxy
2 Jun 08
Other Events
12:00am
8-K
xentqldwi24x dcvz
2 Jun 08
Imclone Appoints DR. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
12:00am
8-K
4dwz0o
16 May 08
Departure of Directors or Principal Officers
12:00am
8-K
76vyse qiwaeil2s
16 May 08
Erbitux® (Cetuximab) Data Demonstrate Improvements
12:00am
8-K
im3sj
2 May 08
Departure of Directors or Principal Officers
12:00am
8-K
l0y 3l46w3g
24 Apr 08
Imclone Systems Reports First Quarter 2008 Financial Results
12:00am
8-K
41wexpwmccl4zfd2yjb
23 Apr 08
Imclone Announces Agreement with Fda on Special Protocol
12:00am
8-K
1zv67i
31 Mar 08
Imclone Appoints Kenneth J. Zuerblis Chief Financial Officer
12:00am
UPLOAD
d6bdmbc4
1 Feb 08
Letter from SEC
12:00am
CORRESP
i8u95n
1 Feb 08
Correspondence with SEC
12:00am
8-K
c4ypm m5t0ibl4bd00
31 Jan 08
Imclone Systems Reports Fourth Quarter and Full Year 2007
12:00am
UPLOAD
sfmqkk5enyym ae3
25 Jan 08
Letter from SEC
12:00am
UPLOAD
5zskmwf
18 Jan 08
Letter from SEC
12:00am
8-K
ynhzz0171e9z
11 Jan 08
Departure of Directors or Principal Officers
12:00am
8-K
mxb8tkyn
14 Dec 07
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
18a2nzhb5
13 Dec 07
Imclone and Sanofi-aventis Settle Patent Litigation with Yeda Research and Development Corporation
12:00am